Teva Turnaround Hung Up By The Uncertain Cost Of Settling Opioid Cases

 
• By Jessica Merrill

Teva's business appears to be stabilizing but the company needs to resolve outstanding opioid liability litigation. CEO Schultz said he is hopeful a national  settlement framework will be finalized.

SC1911_U-Turn_763128463_1200.jpg
Teva's effort to turn the business around faces a big obstacle • Source: Shutterstock

More from Earnings

More from Business